✦Specialist Care · Selected Partner Hospital Pathways · International Patient Coordination✦

Home About Us

Blog Contact

Start Assessment

Home About Us Blog Contact

Treatments

Select Language

Start Assessment Message us on WhatsApp

Back to Library

IVF

Patient Care Information

IVF Success Rates in Cyprus (2026): Published Clinic Data, Age Groups & Reporting Standards

Published: 2026-05-10

Last Updated: 2026-08-23

Meva Clinic Fertility Care Team

3 Min Read

IVF Success Rates in Cyprus (2026): Published Clinic Data, Age Groups & Reporting Standards

An authoritative medical review examining published 2025 clinic data from a partner IVF clinic in Northern Cyprus, distinguishing pregnancy endpoints, age brackets, and donor cycles.

Meva Clinic supports and coordinates international patient pathways with selected partner fertility clinics and specialized reproductive teams in Northern Cyprus and Istanbul. When evaluating assisted reproductive technology (ART) options abroad, prospective patients benefit from transparent, source-verified clinical data. Below, we examine published clinical performance figures, age-stratified outcomes, and essential diagnostic considerations. Explore our specialized care pathway on IVF Cyprus Special.

Clinical Assessment

Would you like a confidential medical review?

Share your treatment question with our international patient team. Suitability and treatment decisions are confirmed by the responsible licensed physician after clinical assessment.

Please do not send sensitive medical documents in your first message. Our team will explain the secure next step.

Ask on WhatsApp Send an Email

Published 2025 Clinical Data: Autologous IVF/ICSI (Own Eggs)

Published 2025 data from our partner IVF clinic in Northern Cyprus reports an IVF/ICSI success rate of 68% for patients aged 25–30, 59% for ages 30–35, 44% for ages 35–40, and 31% for ages 40–45. Results vary according to age, ovarian reserve, sperm quality, and the individual treatment plan. The clinic reports this figure as a treatment success rate rather than a published live-birth rate.

Published 2025 Donor-Egg Outcomes and Beta-hCG Evaluation Methodology

For donor-egg treatment cycles, published 2025 data from our partner IVF clinic in Northern Cyprus reports clinic-reported pregnancy outcomes across maternal age brackets: 86% for ages 25–30, 83% for ages 30–35, 80% for ages 35–40, 73% for ages 40–45, 69% for ages 45–50, and 56% for ages 50+. The clinic indicates that these outcomes are evaluated per treatment cycle using two sequential quantitative beta-hCG blood tests performed approximately 48 hours apart, based on an annual program of over 500 total egg-donation cycles in 2025. In accordance with international terminology (such as ASRM definitions), sequential beta-hCG measurements establish biochemical pregnancy outcomes per treatment cycle rather than ultrasound-confirmed clinical pregnancy or live-birth rates.

Summary Table: Published 2025 Clinic Data in Northern Cyprus

Patient Age Bracket	Autologous IVF/ICSI (Own Eggs)	Donor Egg Treatment Cycles	Clinical Reporting Context
Age 25–30	68%	86%	Published 2025 clinic data (partner IVF clinic, Northern Cyprus).
Age 30–35	59%	83%	Evaluated via sequential beta-hCG blood testing.
Age 35–40	44%	80%	Donor cycles utilize young, screened donor oocytes.
Age 40–45	31%	73%	Uterine receptivity & individual health remain critical.
Age 45–50	Individual Assessment	69%	Comprehensive medical feasibility review required.
Age 50+	Individual Assessment	56%	Cardiovascular & obstetric safety screening mandatory.

Understanding Outcome Metrics: Pregnancy vs. Live Birth

In reproductive medicine, international regulatory bodies (such as the UK Human Fertilisation and Embryology Authority - HFEA and ESHRE) emphasize distinguishing between positive pregnancy tests (beta-hCG confirmation), clinical pregnancy (ultrasound confirmation of fetal heartbeat at 6–7 weeks), and live birth (delivery of a living infant). Treatment protocols, laboratory choices (such as ICSI or blastocyst culture), and individual patient biology determine final outcomes. To learn more about travel and treatment coordination, consult our Istanbul to Cyprus IVF Travel Guide.

Frequently Asked Questions

Are published clinic success rates a guarantee of individual success?↓

No. Statistical figures from clinic reports provide general reference benchmarks. Individual success depends on specific medical factors including ovarian reserve (AMH/AFC), embryo chromosomal euploidy, and endometrial health.

How are donor egg candidates screened in Cyprus?↓

Partner clinics follow stringent medical, genetic, infectious disease, and psychological screening protocols in accordance with applicable health regulations in Northern Cyprus.

Clinical Assessment

Would you like a confidential medical review?

Share your treatment question with our international patient team. Suitability and treatment decisions are confirmed by the responsible licensed physician after clinical assessment.

Please do not send sensitive medical documents in your first message. Our team will explain the secure next step.

Ask on WhatsApp Send an Email

Patient Care Information

Meva Clinic Clinical Care Team

Clinical Governance & Specialist Pathway Standards

This content is maintained by Meva Clinic’s Clinical Care Team for patient guidance and clinical transparency. Final treatment suitability, operating physician assignment, surgical planning, and medical decisions are confirmed only after medical history review, in-person consultation, diagnostic tests, anesthesia evaluation, and doctor availability.

Meva Clinic Clinical Care

Partner Hospital Quality & Medical Network Standards

JCI Partner Hospitals

ISO / TÜV Quality Standards

Licensed Providers in Türkiye

ISAPS-Affiliated Partner Surgeons

International Quality Management

Accreditation and society references relate to selected partner hospitals, provider institutions, or individual partner surgeons where applicable. Meva Clinic coordinates international patient care through licensed healthcare providers and specialist medical partners.